Alnylam Pharmaceuticals (ALNY) Q4 2019 Earnings

31OctConfirmed
Q1 2019
Q2 2019
Q3 2019
Q4 2019
-2.3
-2.11
-1.92
-1.73

Details

Expected EPS
-2
Actual EPS
-1.92
Surprise EPS
0.08
Surprise Percent
+4%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -1.92 per share for Q4 2019.

0 Comments

Share your thoughts